JP2024524270A5 - - Google Patents

Info

Publication number
JP2024524270A5
JP2024524270A5 JP2023579317A JP2023579317A JP2024524270A5 JP 2024524270 A5 JP2024524270 A5 JP 2024524270A5 JP 2023579317 A JP2023579317 A JP 2023579317A JP 2023579317 A JP2023579317 A JP 2023579317A JP 2024524270 A5 JP2024524270 A5 JP 2024524270A5
Authority
JP
Japan
Prior art keywords
muscle
sequence
vector
promoter
expression cassette
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023579317A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524270A (ja
Filing date
Publication date
Priority claimed from GBGB2108997.4A external-priority patent/GB202108997D0/en
Application filed filed Critical
Priority claimed from PCT/GB2022/051611 external-priority patent/WO2022269269A1/en
Publication of JP2024524270A publication Critical patent/JP2024524270A/ja
Publication of JP2024524270A5 publication Critical patent/JP2024524270A5/ja
Pending legal-status Critical Current

Links

JP2023579317A 2021-06-23 2022-06-23 調節性核酸配列 Pending JP2024524270A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2108997.4A GB202108997D0 (en) 2021-06-23 2021-06-23 Regulatory nucleic acid sequences
GB2108997.4 2021-06-23
GB2111317.0 2021-08-05
GB202111317 2021-08-05
PCT/GB2022/051611 WO2022269269A1 (en) 2021-06-23 2022-06-23 Regulatory nucleic acid sequences

Publications (2)

Publication Number Publication Date
JP2024524270A JP2024524270A (ja) 2024-07-05
JP2024524270A5 true JP2024524270A5 (https=) 2025-07-02

Family

ID=82655313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023579317A Pending JP2024524270A (ja) 2021-06-23 2022-06-23 調節性核酸配列

Country Status (8)

Country Link
US (1) US20250129381A1 (https=)
EP (1) EP4359548A1 (https=)
JP (1) JP2024524270A (https=)
KR (1) KR20240023643A (https=)
AU (1) AU2022297795A1 (https=)
CA (1) CA3221707A1 (https=)
IL (1) IL309630A (https=)
WO (1) WO2022269269A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202319008D0 (en) * 2023-12-13 2024-01-24 Ucl Business Ltd AAV-mediated gene therapy of diseases caused by impaired function of GLDC

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US8106180B2 (en) 2003-08-07 2012-01-31 Whitehead Institute For Biomedical Research Methods and products for expression of micro RNAs
US20050142581A1 (en) 2003-09-04 2005-06-30 Griffey Richard H. Microrna as ligands and target molecules
WO2005056761A2 (en) 2003-12-05 2005-06-23 Massachusetts Institute Of Technology REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi
KR100614827B1 (ko) 2004-05-06 2006-08-25 재단법인서울대학교산학협력재단 양방향 은닉 마코프 모델을 이용한 완숙한마이크로알엔에이 위치예측방법 및 이를 구현하기 위한컴퓨터 프로그램을 기록한 저장매체
PL3097197T3 (pl) * 2014-01-21 2021-06-28 Vrije Universiteit Brussel Mięśniowo-specyficzne elementy regulatorowe kwasów nukleinowych oraz sposoby i ich zastosowanie
TWI908746B (zh) * 2019-11-28 2025-12-21 美商銳進科斯生物股份有限公司 微小肌縮蛋白基因療法之構築體及其用途
EP4081643A1 (en) * 2019-12-24 2022-11-02 Asklepios Biopharmaceutical, Inc. Regulatory nucleic acid sequences
EP4192580A4 (en) * 2020-08-05 2025-06-18 AskBio Inc. Methods for treating heart disease and congestive heart failure and administration of AAV vectors
CA3195177A1 (en) * 2020-10-07 2022-04-14 Asklepios Biopharmaceutical, Inc. Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy disorders including limb girdle 2i (lgmd2i)

Similar Documents

Publication Publication Date Title
Bostick et al. Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice
KR102584655B1 (ko) 조절성 폴리뉴클레오티드
JP7415042B2 (ja) プラコフィリン2遺伝子治療の方法および組成物
JP2020503869A (ja) トリプルガイド配列と共にcrispr/cas9を用いるエクソンスキッピング改変のための最適化戦略
JP2024050553A (ja) 不整脈源性右心室心筋症における電気的機能及び心臓機能並びに心構造を回復するための遺伝子療法戦略
JP2006524691A (ja) 心臓導電系の標的化された領域の遺伝子修飾
US11781156B2 (en) Plakophillin-2 gene therapy methods and compositions
JP2023509118A5 (https=)
JP2024524270A5 (https=)
CN113730388A (zh) 辛酸钠在制备改善心肺复苏效果以及心肺复苏后多器官功能障碍的药物中的应用
Southall et al. Imipramine poisoning: survival of a child after prolonged cardiac massage
TW202400798A (zh) 斑菲素蛋白—2(plakophillin—2)基因療法之治療方法
CN108888753B (zh) 酸性糖蛋白orm在制备治疗心力衰竭药物中的应用
CN115287276A (zh) Sem1蛋白、表达sem1蛋白工程化益生菌在制备治疗和/或预防心脏病药物中的应用
JP2023525476A5 (https=)
Wittlieb-Weber et al. A novel GJA1 mutation causing familial oculodentodigital dysplasia with dilated cardiomyopathy and arrhythmia
JP2023540545A5 (https=)
CN117378563B (zh) 一种肺动脉高压动物模型的构建方法及其应用
US20250360171A1 (en) Chemogenetically gated ion channels and use thereof
Bin et al. Effects of remote ischemic preconditioning on early myocardial post-infarction remodeling
Qiao et al. A Natural Sweetener‐inducible Genetic Switch Controls Therapeutic Protein Expression in Mammals
Salvini et al. Myocarditis Associated with Coronavirus Disease 2019 (COVID-19) in a Pediatric Patient
WO2024125494A1 (zh) 一种基因调节的方法及其应用
Kim et al. Pathological substratum for a case of fulminant myocarditis treated with extracorporeal membrane oxygenation and subsequent heart transplantation
SHIMAMOTO et al. Bacterial Adrenaline Sensitizer in Adrenaline (Noradrenaline) Arteriosclerosis and Adrenaline (Noradrenaline) Myocardial Infarction A Preliminary Report